HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norito Katoh Selected Research

Steroids

7/2019Treatment rationale and design of a phase II study of narrow-band ultraviolet B phototherapy for cutaneous steroid-refractory acute graft-vs-host disease following allogenic stem-cell transplantation.
1/2019[A CASE OF CHILDHOOD-ONSET EOSINOPHILIC GRANULOMATOUS POLYANGIITIS WITH ASYMPTOMATIC MYOCARDIAL INVOLVEMENT WHO WAS DIAGNOSED AT MORE THAN 5 YEARS AFTER ONSET OF ATOPIC DERMATITIS AND BRONCHIAL ASTHMA].
7/2018Influence of topical steroids on intraocular pressure in patients with atopic dermatitis.
7/2015Contact sensitivity in patients with recalcitrant atopic dermatitis.
3/2004Effects of tacrolimus ointment on facial eruption, itch, and scratching in patients with atopic dermatitis.
7/2003Combination of calcipotriol and clobetasol propionate as a premixed ointment for the treatment of psoriasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norito Katoh Research Topics

Disease

29Atopic Dermatitis (Atopic Eczema)
03/2022 - 05/2002
14Neoplasms (Cancer)
07/2022 - 07/2006
13Inflammation (Inflammations)
02/2021 - 10/2005
13Drug Eruptions (Drug Eruption)
01/2019 - 01/2006
12Melanoma (Melanoma, Malignant)
02/2016 - 07/2006
11Hypersensitivity (Allergy)
01/2022 - 09/2004
11Allergic Contact Dermatitis
11/2021 - 05/2007
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2020 - 01/2007
7Contact Dermatitis (Eczema, Contact)
01/2021 - 08/2003
7Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020 - 07/2003
6Anaphylaxis (Anaphylactic Shock)
01/2022 - 07/2011
5Pruritus (Itching)
09/2020 - 03/2004
5Wounds and Injuries (Trauma)
12/2015 - 05/2006
4Psoriatic Arthritis
07/2022 - 01/2013
4Eczema
01/2020 - 01/2006
4Skin Diseases (Skin Disease)
07/2019 - 10/2007
3Infections
03/2022 - 06/2005
3Erythema
01/2021 - 01/2006
3Cheilitis
06/2020 - 10/2003
3Asthma (Bronchial Asthma)
04/2020 - 01/2009
3Autoimmune Diseases (Autoimmune Disease)
01/2020 - 02/2007
3Hemangiosarcoma (Angiosarcoma)
12/2018 - 04/2015
3Eosinophilia
07/2017 - 12/2008
2Alopecia Areata
05/2021 - 07/2020
2Mycosis Fungoides
02/2021 - 01/2014
2Erythema Nodosum
01/2020 - 06/2005
2Exanthema (Rash)
07/2019 - 01/2009
2Carcinoma (Carcinomatosis)
12/2018 - 05/2012
2Diffuse alopecia
12/2016 - 01/2013
2Dermatitis
05/2014 - 04/2011
2Urticaria (Hives)
05/2014 - 06/2009
2Alopecia (Baldness)
01/2013 - 04/2009
2Erythema Multiforme
12/2012 - 12/2011
2Immediate Hypersensitivity
07/2011 - 01/2006
2Allergic Rhinitis
07/2011 - 01/2009
1COVID-19
07/2022
1Coronavirus Infections
07/2022
1Anemia
03/2022

Drug/Important Bio-Agent (IBA)

11Immunoglobulin E (IgE)IBA
09/2020 - 09/2004
9Adrenal Cortex Hormones (Corticosteroids)IBA
03/2022 - 01/2003
9Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2003
7Ointments (Pastes)IBA
07/2020 - 07/2003
6Tacrolimus (Prograf)FDA LinkGeneric
07/2020 - 01/2003
6SteroidsIBA
07/2019 - 07/2003
5dupilumabIBA
01/2022 - 04/2020
5AntigensIBA
02/2015 - 09/2004
5EnzymesIBA
05/2014 - 07/2006
4Toll-Like Receptor 3IBA
02/2021 - 02/2015
4Interleukin-33IBA
09/2020 - 10/2009
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2020 - 12/2008
4Messenger RNA (mRNA)IBA
01/2016 - 05/2006
4CytokinesIBA
05/2014 - 05/2006
3Immune Checkpoint InhibitorsIBA
07/2022 - 01/2016
3NivolumabIBA
07/2022 - 01/2016
3upadacitinibIBA
03/2022 - 01/2021
3AllergensIBA
01/2022 - 09/2004
3EmollientsIBA
07/2020 - 10/2016
3Picryl Chloride (Trinitrochlorobenzene)IBA
11/2017 - 05/2014
3SodiumIBA
10/2015 - 05/2006
3Pharmaceutical PreparationsIBA
04/2015 - 01/2009
3InterleukinsIBA
01/2015 - 10/2005
3ImmunosorbentsIBA
05/2014 - 07/2006
3P-SelectinIBA
04/2010 - 06/2007
2Imiquimod (Aldara)FDA LinkGeneric
07/2022 - 01/2014
2Janus Kinase InhibitorsIBA
03/2022 - 01/2021
2Creatine Kinase (Creatine Phosphokinase)IBA
03/2022 - 01/2021
2Ophthalmic Solutions (Eye Drops)IBA
09/2021 - 01/2010
2Clobetasol (Clobetasol Propionate)FDA LinkGeneric
05/2021 - 07/2003
2Infliximab (Remicade)FDA Link
02/2021 - 01/2020
2Adalimumab (Humira)FDA Link
01/2021 - 01/2020
2Irritants (Vesicants)IBA
01/2021 - 02/2015
2LigandsIBA
09/2020 - 01/2016
2Interleukin-2 Receptors (IL 2 Receptor)IBA
09/2020 - 09/2013
2Interleukin-17 (Interleukin 17)IBA
07/2020 - 01/2020
2Soaps (Soap)IBA
04/2020 - 07/2018
2C-Reactive ProteinIBA
01/2020 - 04/2011
2HaptensIBA
11/2017 - 06/2007
2interleukin-21 (interleukin 21)IBA
07/2017 - 07/2011
2ChemokinesIBA
07/2017 - 05/2014
2InterferonsIBA
02/2016 - 10/2010
2Interferon-betaIBA
07/2015 - 12/2012
2Small Interfering RNA (siRNA)IBA
04/2015 - 04/2010
2Phosphates (Orthophosphate)IBA
03/2015 - 05/2006
2AcidsIBA
05/2014 - 08/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2014 - 05/2006
2TabletsIBA
12/2013 - 01/2013
2Fluconazole (Zonal)FDA LinkGeneric
03/2013 - 01/2013
2erucylphosphocholineIBA
03/2012 - 05/2006
2CollagenIBA
03/2012 - 04/2011
2Chemokine CXCL12IBA
03/2012 - 05/2006
2Peptides (Polypeptides)IBA
01/2009 - 07/2006
1pembrolizumabIBA
07/2022
1mRNA VaccinesIBA
07/2022

Therapy/Procedure

19Therapeutics
07/2022 - 07/2006
7Radiotherapy
01/2020 - 05/2012
4Aftercare (After-Treatment)
01/2020 - 01/2009
3Drug Therapy (Chemotherapy)
01/2020 - 01/2013
3Phototherapy (Light Therapy)
07/2019 - 10/2007
2Cryotherapy (Therapy, Cold)
02/2020 - 04/2010
2Immunotherapy
01/2016 - 07/2006